Skip to content
Open access · CC-BY via OpenAlex

Targeting cellular senescence with novel senotherapeutics by design to extend healthspan

Lei Justan Zhang, Brian M. Hughes, Luise A. Angelini, Ryan D. O'Kelly, Matthew J. Yousefzadeh, Ted Kamenecka, Laura J. Niedernhofer, Paul D. Robbins

Innovation in Aging · 2021

Abstract

Abstract Senescent cells accumulate with age in various tissues and organs, leading to the decline in tissue function and deterioration of many age-related diseases and aging. Senolytics(definition) have emerged as an effective therapeutic approach to eliminate senescent cells to improve aging phenotypes and associated co-morbidities. Despite their promising potential, only a handful of senolytics have been reported, including a natural flavonoid fisetin discovered by our group. Fisetin has been shown to reduce senescence(definition), suppress age-related pathology, and extend healthspan(definition) in aged mice. However, its moderate potency, potential mutagenic risk and poor bioavailability have limited its further clinical applications. By leveraging drug design, medicinal chemistry and high-content imaging analysis, we have successfully optimized the senolytic activity of fisetin, leading to the identification of two improved fisetin senolytic analogs (FAs) with reduced toxicity in non-senescent cells. The improved senolytic activity of these FAs was demonstrated in murine and human senescent cell models as well as in accelerated aging and naturally aged mouse models. The analysis of the senolytic activity of the FAs as well as several other recently identified senolytics, including a senolytic lipid, will be presented.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/geroni/igab046.2564
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
Zhang, L.J., Hughes, B.M., Angelini, L.A., O'Kelly, R.D., Yousefzadeh, M.J., Kamenecka, T., Niedernhofer, L.J., &amp; Robbins, P.D. (2021). Targeting cellular senescence with novel senotherapeutics by design to extend healthspan. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igab046.2564
Vancouver
Zhang LJ, Hughes BM, Angelini LA, O'Kelly RD, Yousefzadeh MJ, Kamenecka T, et al. Targeting cellular senescence with novel senotherapeutics by design to extend healthspan. Innovation in Aging. 2021. doi:10.1093/geroni/igab046.2564.
BibTeX
@article{lei2021Target, title = {Targeting cellular senescence with novel senotherapeutics by design to extend healthspan}, author = {Lei Justan Zhang and Brian M. Hughes and Luise A. Angelini and Ryan D. O'Kelly and Matthew J. Yousefzadeh and Ted Kamenecka and Laura J. Niedernhofer and Paul D. Robbins}, journal = {Innovation in Aging}, year = {2021}, doi = {10.1093/geroni/igab046.2564}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings